MDX

QuidelOrtho announces strategy to accelerate growth in molecular diagnostics

June 5, 2025

QuidelOrtho Corporation announced a refocusing of its molecular diagnostics strategy. This strategy includes the intent to acquire full ownership of LEX Diagnostics after...

MDX

Syndromic tests expand the medical laboratory’s growing stewardship role

Marti Juanola Falgarona, PhD

March 21, 2025

MDX

Blood test could improve lung cancer outcomes, Yale finds

Erin Brady

March 17, 2025

MDX

Fluxergy announces NIAID collaboration

LABline

Nov. 21, 2024

MDX

Q&A with Nathan Patton, vice president of marketing for Near Patient Care at Roche Diagnostics

MLO Staff

Oct. 30, 2024

MDX

Q&A with Jackie Weiss, PhD, scientific affairs liaison at EUROIMMUN US (part of Revvity)

MLO Staff

Oct. 29, 2024

MDX

MLO releases findings of 2024 SOI survey on MDx

Kara Nadeau

Oct. 28, 2024

More quality assurance measures enacted, greater concerns over LDT access, fewer supply chain issues reported among medical laboratory professionals

MDX

Navigating the landscape of hepatitis B: Symptoms, causes, and testing

Youssef Maakaroun

June 24, 2024

Hepatitis B virus (HBV), despite widespread vaccination efforts, poses a global health challenge affecting around 2 billion people worldwide.1 Chronic HBV contributes to 30% of...

MDX

Diasorin receives FDA 510(K) Clearance for the LIAISON PLEX Blood Culture Yeast Assay on the new multiplexing LIAISON PLEX

LABline

June 6, 2024

It is the second multiplexing molecular diagnostic panel on the LIAISON PLEX to be cleared by the U.S. FDA after the Respiratory Flex Assay, which received clearance in March ...

MDX

Diasorin receives FDA 510(k) clearance for the updated syndromic panel NxTAG Respiratory Pathogen Panel v2

LABline

May 20, 2024

NxTag Respiratory Pathogen Panel (RPP) v2 is a molecular multiplex panel that detects 21 different pathogens (bacteria, viruses).

MDX

Revvity’s EUROIMMUN and ALPCO-GeneProof announce strategic partnership to expand CE-IVD molecular assay offerings

LABline

May 7, 2024

New diagnostic partnership.

MDX

Next-generation sequencing in laboratory medicine

Rajasri Chandra, MS, MBA

April 22, 2024

Advancements in sequencing techniques and the emergence of next-generation sequencing (NGS) technology have transformed laboratory medicine and clinical diagnosis. DNA sequencing...

MDX

PathogenDx launches novel D3 Array multiplexed molecular diagnostics technology for UTI pathogen detection and antibiotic resistance

LABline

Feb. 8, 2024

New product.

MDX

Molecular diagnostics research featured in the January issue of ADLM’s The Journal of Applied Laboratory Medicine

LABline

Jan. 17, 2024

Molecular diagnostics is a powerful branch of laboratory medicine that examines the fundamental genetic and biochemical components of life to provide invaluable insights into ...

MDX

Factors to consider in molecular diagnostics testing during the preanalytical phase

Dr. Eric Gonzalez Garcia

Dec. 18, 2023

Molecular diagnostics applies techniques of molecular biology to diagnose disease, as well as predict its course; select appropriate treatments; and monitor treatments’ ...